20th Annual Meeting of the
Oligonucleotide Therapeutics Society

October 6-9, 2024
Montreal, Quebec, Canada
Centre Mont-Royal

2024 OTS Annual Meeting – Scientific Organizing Committee Chairs

David Corey, Ph.D
UT Southwestern
Medical Center at Dallas

Masad Damha, Ph.D
McGill University

Laura Sepp-Lorenzino, Ph.D
CSO, Intellia Therapeutics

Committee Members:

  • Jathavan Asohan, PhD Candidate, McGill University

  • Isabel Aznarez, PhD, Stoke Therapeutics

  • Steven Dowdy, Ph.D, Professor, UCSD School of Medicine

  • Hassan Fakih, PhD, UMass Chan Medical School / RTI

  • Richard Geary, PhD, Ionis Pharmaceuticals

  • Jonathan Hall, PhD, ETH Zürich

  • Maja Janas, PhD, DABT, Alnylam Pharmaceuticals

  • Art Krieg, MD, UMASS Chan Medical School

  • Eva-Maria Manz, PhD Candidate, ETH Zürich

  • Rebecca Miles, PhD, CEO, ReiNA Consulting LLC

  • Marie Wikström Lindholm, Ph.D, Silence Therapetuics